Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

被引：0
|
作者：
Thomas Urup
Line Mærsk Staunstrup
Signe Regner Michaelsen
Kristoffer Vitting-Seerup
Marc Bennedbæk
Anders Toft
Lars Rønn Olsen
Lars Jønson
Shohreh Issazadeh-Navikas
Helle Broholm
Petra Hamerlik
Hans Skovgaard Poulsen
Ulrik Lassen
机构：
[1] Rigshospitalet,Department of Radiation Biology, The Finsen Center, Section 6321
[2] University of Copenhagen,Section for Computational and RNA biology (SCARB), Department of Biology
[3] Rigshospitalet,Center for Genomic Medicine
[4] University of Copenhagen,Department of Biology, The Bioinformatics Centre
[5] Technical University of Denmark,Department of Systems Biology, Center for Biological Sequence Analysis
[6] University of Copenhagen,Neuroinflammation Unit, BRIC
[7] Rigshospitalet,Department of Pathology, Center of Diagnostic Investigation
[8] Danish Cancer Society Research Center,Brain Tumor Biology Group
[9] Rigshospitalet,Department of Oncology, The Finsen Center
[10] Rigshospitalet,Phase I Unit, The Finsen Center
来源：
BMC Cancer | / 17卷
关键词：
Anti-angiogenic; RNA-sequencing; Protein kinase C; Reverse mesenchymal transition; TGF-beta;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
    Urup, Thomas
    Staunstrup, Line Maersk
    Michaelsen, Signe Regner
    Vitting-Seerup, Kristoffer
    Bennedbaek, Marc
    Toft, Anders
    Olsen, Lars Ronn
    Jonson, Lars
    Issazadeh-Navikas, Shohreh
    Broholm, Helle
    Hamerlik, Petra
    Poulsen, Hans Skovgaard
    Lassen, Ulrik
    [J]. BMC CANCER, 2017, 17
  • [2] TRANSCRIPTIONAL CHANGES INDUCED BY BEVACIZUMAB COMBINATION THERAPY IN RESPONDING AND NON-RESPONDING RECURRENT GLIOBLASTOMA PATIENTS
    Urup, T.
    Staunstrup, L.
    Michaelsen, S.
    Vitting-Seerup, K.
    Bennedbaek, M.
    Toft, A.
    Broholm, H.
    Hamerlik, P.
    Poulsen, H.
    Lassen, U.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 40 - 41
  • [3] Clinical benefit of bevacizumab in responding and non-responding patients with metastatic colorectal cancer
    Mass, R.
    Sarkar, S.
    Holden, S. N.
    Hurwitz, H. I.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 182 - 182
  • [4] MICRORNA EXPRESSION PROFILING OF RESPONDING AND NON-RESPONDING CML-PATIENTS TO IMATINIB THERAPY
    Bruhn, O.
    Diewock, T.
    Pott, C.
    Kneba, M.
    Haenisch, S.
    Cascorbi, I
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 310 - 311
  • [5] MicroRNA expression profiling of responding and non-responding CML-patients to imatinib therapy
    Diewock, T.
    Kaehler, M.
    Pott, C.
    Kneba, M.
    Haenisch, S.
    Cascorbi, I
    Bruhn, O.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S46 - S46
  • [6] ALTERNATIVE TREATMENTS FOR NON-RESPONDING PATIENTS
    KANE, JM
    KINON, B
    PEROVICH, R
    JOHNS, C
    [J]. SCHIZOPHRENIA RESEARCH, 1992, 6 (02) : 108 - 109
  • [7] Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients
    Jamnitski, A.
    Krieckaert, C. L.
    Nurmohamed, M. T.
    Hart, M. H.
    Dijkmans, B. A.
    Aarden, L.
    Voskuyl, A. E.
    Wolbink, G. J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (01) : 88 - 91
  • [8] Clinical benefit from bevacizumab (BV) in responding (R) and non-responding (NR) patients (pts) with metastatic colorectal cancer (mCRC).
    Mass, RD
    Sarkar, S
    Holden, SN
    Hurwitz, H
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 249S - 249S
  • [9] PLASMA-EXCHANGE IN CHRONIC PROGRESSIVE POLYRADICULONEUROPATHY - COMPARISON OF RESPONDING TO NON-RESPONDING PATIENTS
    TANDAN, R
    DONOFRIO, PD
    ALBERS, JW
    [J]. ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1984, 57 (05): : P86 - P86
  • [10] What are demographic and EEG differences between responding and non-responding panic disorder patients
    Kamaradova, Dana
    Prasko, Jan
    Brunovsky, Martin
    Grambal, Ales
    Diveky, Tomas
    Latalova, Klara
    [J]. NEUROENDOCRINOLOGY LETTERS, 2013, 34 (02) : 162 - 171
12345